Paolo Tombesi
2021 - Turning Point Therapeutics
In 2021, Paolo Tombesi earned a total compensation of $4.6M as Executive Vice President and Chief Financial Officer at Turning Point Therapeutics.
Compensation breakdown
| Bonus | $250,000 |
|---|---|
| Non-Equity Incentive Plan | $247,690 |
| Option Awards | $2,609,323 |
| Salary | $204,735 |
| Stock Awards | $1,227,548 |
| Other | $38,766 |
| Total | $4,578,062 |
Tombesi received $2.6M in option awards, accounting for 57% of the total pay in 2021.
Tombesi also received $250K in bonus, $247.7K in non-equity incentive plan, $204.7K in salary, $1.2M in stock awards and $38.8K in other compensation.
Rankings
In 2021, Paolo Tombesi's compensation ranked 2,887th out of 12,406 executives tracked by ExecPay. In other words, Tombesi earned more than 76.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,887 out of 12,406 | 77th |
Division Manufacturing | 1,148 out of 5,494 | 79th |
Major group Chemicals And Allied Products | 454 out of 2,369 | 81st |
Industry group Drugs | 398 out of 2,090 | 81st |
Industry Pharmaceutical Preparations | 266 out of 1,537 | 83rd |
Source: SEC filing on April 29, 2022.
Tombesi's colleagues
We found six more compensation records of executives who worked with Paolo Tombesi at Turning Point Therapeutics in 2021.
2021
Athena Countouriotis
Turning Point Therapeutics
Chief Executive Officer
2021
Mohammad Hirmand
Turning Point Therapeutics
Chief Medical Officer
2021
Annette North
Turning Point Therapeutics
General Counsel
2021
Siegfried PHD
Turning Point Therapeutics
Chief Scientific Officer
2021
Yi Larson
Turning Point Therapeutics
Chief Financial Officer
2021
Brian Baker
Turning Point Therapeutics
Former Senior Vice President, Finance and Administration
News
Turning Point Therapeutics CEO Athena Countouriotis' 2021 pay rises 11% to $17M
April 29, 2022
Epizyme CEO Robert Bazemore's 2020 pay jumps 103% to $8.5M
April 29, 2021
Epizyme CEO Robert Bazemore's 2019 pay rises 14% to $4.2M
April 17, 2020
INSMED CEO William Lewis' 2019 pay jumps 21% to $7.2M
March 31, 2020
INSMED CEO William Lewis' 2018 pay jumps 37% to $5.9M
April 4, 2019